A Supplement to TRANSFUSION: The THOR Network 2012 Remote Damage Control Resuscitation Symposium has been published:


Transfusion for remote damage control resuscitation
R.B. Weiskopf and P.M. Ness

The Solstrand Remote Damage Control Resuscitation Symposium
G. Strandenes and P.C. Spinella

Remote damage control resuscitation and the Solstrand Conference: defining the need, the language, and a way forward
R.T. Gerhardt, G. Strandenes, A.P. Cap, F.J. Rentas, E. Glassberg, J. Mott, M.A. Dubick, and P.C. Spinella for the THOR Network and RemTORN Study Groups

Practical translation of hemorrhage control techniques to the civilian trauma scene
D.J. Lockey, A.E. Weaver, and G.E. Davies

Pathogenesis of acute traumatic coagulopathy
R. Davenport

Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options
M. Maegele

The microcirculation: linking trauma and coagulopathy
K.R. Ward

Prehospital detection of traumatic coagulopathy
J.S. Hagemo

Near infrared spectroscopy: clinical and research uses
D.A. Hampton and M.A. Schreiber

The development and feasibility of a remote damage control resuscitation prehospital plasma transfusion protocol for warfarin reversal for patients with traumatic brain injury
M.D. Zielinski, D.L. Smoot, J.R. Stubbs, D.H. Jenkins, M.S. Park, and S.P. Zietlow

The evolving role of lyophilized plasma in remote damage control resuscitation in the French Armed Forces Health Service
A. Sailliol, C. Martinaud, A.P. Cap, C. Civadier, B. Clavier, A.-V. Deshayes, A.-C. Mendes, T. Pouget, N. Demazeau, M. Chueca, F.-R. Martelet, and S. Ausset

The use of lyophilized plasma in a severe multi-injury pig model
T.H. Lee, P.Y. Van, N.J. Spoerke, G.J. Hamilton, S.D. Cho, K. Watson, J. Differding, and M.A. Schreiber

Spray-dried plasma and fresh frozen plasma modulate permeability and inflammation in vitro in vascular endothelial cells
K. Wataha, T. Menge, X. Deng, A. Shah, A. Bode, J.B. Holcomb, D. Potter, R. Kozar, P.C. Spinella, and S. Pati

The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding
D. Fries

Tranexamic acid in remote damage control resuscitation
J.F. Rappold and A.E. Pusateri

Thrombosomes: a platelet-derived hemostatic agent for control of noncompressible hemorrhage
G.M. Fitzpatrick, R. Cliff, and N. Tandon

Fresh whole blood use by forward surgical teams in Afghanistan is associated to improved survival compared to component therapy without platelets
S.C. Nessen, B.J. Eastridge, D. Cronk, R.M. Craig, O. Berséus, R. Ellison, K. Remick, J. Seery, A. Shah, and P.C. Spinella

Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma
O. Berséus, K. Boman, S.C. Nessen, and L.A. Westerberg

Blood Far Forward—a whole blood research and training program for austere environments
G. Strandenes, A.P. Cap, D. Cacic, T.H.F. Lunde, H.S. Eliassen, T. Hervig, and P.C. Spinella

Development of a riboflavin and ultraviolet light-based device to treat whole blood
H.L. Reddy, S.K. Doane, S.D. Keil, S. Marschner, and R.P. Goodrich

Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and
refrigeration effects over time
H.F. Pidcoke, S.J. McFaul, A.K. Ramasubramanian, B.K. Parida, A.G. Mora, C.G. Fedyk, K.K. Valdez-Delgado, R.K. Montgomery, K.M. Reddoch, A.C. Rodriguez, J.K. Aden, J.A. Jones, R.S. Bryant, M.R. Scherer, H.L. Reddy, R.P. Goodrich, and A.P. Cap